Marigold Capital

Marigold Capital is an impact-oriented investor with a thesis tilted toward social outcomes, including health equity, community wellbeing, and inclusive economic development. Public information on fund size, stage discipline, and check sizes is limited, so founders should treat it as a small, conviction-driven vehicle writing checks plausibly in the $250k to $1M range at seed. Healthcare exposure runs through health equity, women’s health, mental health, and community care models rather than capital-intensive therapeutics or devices. Physician founders building care models for underserved populations, behavioral health platforms, or equity-focused digital health products are the natural fit. Founders building scaled growth-stage rounds, hospital-enterprise software, or therapeutics should pitch elsewhere. Geographic posture is most likely North American with global impact-deal capacity. The realistic entry path is a warm introduction from an impact ecosystem operator, an existing portfolio founder, or a foundation program officer in the firm’s network. Founders should arrive with a credible impact thesis, real outcome data, and a clear path to commercial sustainability rather than relying on grant capital alone. Treat Marigold as a values-aligned co-investor that brings impact diligence rigor and network depth in the social-outcomes ecosystem, but plan to source a larger lead investor from a generalist or healthcare-specialist fund when the company scales.